title: Erlotinib associated with rosacea-like folliculitis and Malassezia sympodialis.
authors.forename: M S
authors.initials: MS
authors.lastname: Cuétara
authors.forename: A
authors.initials: A
authors.lastname: Aguilar
authors.forename: L
authors.initials: L
authors.lastname: Martin
authors.forename: C
authors.initials: C
authors.lastname: Aspiroz
authors.forename: A
authors.initials: A
authors.lastname: del Palacio
mesh_terms: D000368:Aged; D000970:Antineoplastic Agents / Q000009:adverse effects*; D003881:Dermatomycoses / Q000150:complications; D003875:Drug Eruptions / Q000209:etiology* / Q000382:microbiology; D000069347:Erlotinib Hydrochloride; D005499:Folliculitis / Q000139:chemically induced* / Q000382:microbiology; D006801:Humans; D008290:Malassezia / Q000302:isolation & purification; D008297:Male; D011799:Quinazolines / Q000009:adverse effects*; D012393:Rosacea / Q000139:chemically induced* / Q000382:microbiology
chemical_list: D000970:Antineoplastic Agents; D011799:Quinazolines; D000069347:Erlotinib Hydrochloride